KIN stock forecast
Our latest prediction for Kindred Biosciences, Inc.'s stock price was made on the Dec. 3, 2018 when the stock price was at 13.10$.
In the short term (2weeks), KIN's stock price should outperform the market by 0.56%. During that period the price should oscillate between -8.01% and +10.35%.
In the medium term (3months), KIN's stock price should outperform the market by 3.44%. During that period the price should oscillate between -18.02% and +30.04%.Get email alerts
About Kindred Biosciences, Inc.
Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.49$ per share.
The book value per share is 3.42$
Three months stock forecastDec. 3, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|